Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell Effects-Reference-Cited by-同舟云学术

Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell Effects

Published:2020-09-25 Issue:39 Volume:5 Page:25113-25124
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Hartman Zachary¹,Geldenhuys Werner J.²^ORCID,Agazie Yehenew M.¹³^ORCID

Affiliation:

1. Department of Biochemistry, West Virginia University, Morgantown, West Virginia 26506, United States

2. School of Medicine; Department of Basic Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, West Virginia 26506, United States

3. WVU Cancer Institute, West Virginia University Morgantown, West Virginia 26506, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c02746

Reference47 articles.

1. Mechanisms of receptor tyrosine kinase activation in cancer

2. Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies

3. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance

4. Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling

5. A Common Requirement for the Catalytic Activity and Both SH2 Domains of SHP-2 in Mitogen-activated Protein (MAP) Kinase Activation by the ErbB Family of Receptors

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational study on the binding mechanism of allosteric drug TNO155 inhibiting SHP2E76A;Molecular Diversity;2024-05-28

2. SHP2–EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP Action;The Journal of Physical Chemistry B;2024-05-15

3. Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect;Physical Chemistry Chemical Physics;2024

4. SHP2 is involved in the occurrence, development and prognosis of cancer;Oncology Letters;2023-07-27

5. Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes;ACS Bio & Med Chem Au;2023-07-14